Peanut oral immunotherapy is generally safe, but rare, severe immediate allergic reactions may emerge months into treatment, ...
Testing During Exercise Flags High Risk After Fontan Surgery A higher pulmonary vascular resistance index during exercise, but not at rest, predicts poor clinical outcomes in adults with Fontan ...
Clinicians discuss the rapidly evolving therapies, technology, and surgical approaches for early-stage NSCLC and take a fresh look at the future of care. Teamwork: A Multidisciplinary Approach to ...
PPI Use Linked to Poor Survival Outcomes in Glioblastoma Among patients receiving treatment for glioblastoma, PPI use is associated with worse progression-free and overall survival, a recent ...
Gestational Diabetes Rates Surge in the US Gestational diabetes rates rose in live first singleton pregnancies every year between 2016 and 2024 among all racial and ethnic groups in the US. Medscape ...
Europe’s MDs’ Top 2025 Reads: Burnout, AI, and…Sperm? European doctors came to Medscape Medical News to read about everything from GLP-1s to digital healthcare tools, in addition to a few quirky ...
‘Z-Drug’ Use in Early Pregnancy: New Safety Data Commonly prescribed sleep medications such as zolpidem are not associated with a meaningful increase in the overall risk for birth defects when used in ...
Should AI Tools For Doctors Be Licensed Like Doctors? A new proposal in JAMA Internal Medicine suggests that the FDA should create an approval pathway for medical AI tools that parallels how ...
Aging Europe Faces AF Surge as Clinical Complexity Deepens Approximately 7.6 million individuals aged 65 years or older currently have atrial fibrillation across the EU, and by 2060, the number is ...
Dr JoAnn Manson discusses why the FDA’s removal of the 'black box' warning on hormone therapy is a long-overdue victory for personalized medicine and shared decision-making.
Chemoendocrine therapy shows a greater negative association with patient-reported cognitive decline than endocrine therapy alone in pre- and postmenopausal women with breast cancer.
Restarting Anticoagulants After Brain Bleeds: Worth It? Restarting oral anticoagulants after spontaneous intracerebral haemorrhage reduces the risk for ischaemic stroke but increases the risk for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results